Preliminary considerations regarding the risk of COVID-19 and disease severity in chronic gastrointestinal conditions

The novel RNA betacoronavirus SARS-CoV-2 is driving great efforts in clinical and basic research and several studies of the epidemiology, risk factors, clinical and virological features of this infection are already available. However COVID-19 is a totally new pathological entity, and many gray area...

Descripción completa

Detalles Bibliográficos
Autores principales: Piciucchi, Matteo, Sbrozzi-Vanni, Andrea, Rossi, Alice, Satriano, Alissa, Dell’Amico, Iginio, Francesco, Vincenzo De, Zullo, Angelo, Manta, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2020
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315710/
https://www.ncbi.nlm.nih.gov/pubmed/32624651
http://dx.doi.org/10.20524/aog.2020.0498
Descripción
Sumario:The novel RNA betacoronavirus SARS-CoV-2 is driving great efforts in clinical and basic research and several studies of the epidemiology, risk factors, clinical and virological features of this infection are already available. However COVID-19 is a totally new pathological entity, and many gray areas regarding associated diseases still need to be elucidated, especially in the group of patients who suffer from preexistent gastrointestinal disease. The aim of this review is to summarize the published data on the correlation between chronic gastrointestinal disorders and COVID-19.

Ejemplares similares